Expanding molecular diagnostic capacity for COVID-19 in Ethiopia: operational implications, challenges and lessons learnt.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2021
Historique:
received: 19 12 2020
accepted: 11 01 2021
entrez: 23 4 2021
pubmed: 24 4 2021
medline: 4 5 2021
Statut: epublish

Résumé

Efforts towards slowing down coronavirus (COVID-19) transmission and reducing mortality have focused on timely case detection, isolation and treatment. Availability of laboratory COVID-19 testing capacity using reverse-transcriptase polymerase chain reaction (RT-PCR) was essential for case detection. Hence, it was critical to establish and expand this capacity to test for COVID-19 in Ethiopia. To this end, using a three-phrased approach, potential public and private laboratories with RT-PCR technology were assessed, capacitated with trained human resource and equipped as required. These laboratories were verified to conduct COVID-19 testing with quality assurance checks regularly conducted. Within a 10-month period, COVID-19 testing laboratories increased from zero to 65 in all Regional States with the capacity to conduct 18,454 tests per day. The success of this rapid countrywide expansion of laboratory testing capacity for COVID-19 depended on some key operational implications: the strong laboratory coordination network within the country, the use of non-virologic laboratories, investment in capacity building, digitalization of the data for better information management and establishing quality assurance checks. A weak supply chain for laboratory reagents and consumables, differences in the brands of COVID-19 test kits, frequent breakdowns of the PCR machines and inadequate number of laboratory personnel following the adaption of a 24/7 work schedule were some of the challenges experienced during the process of laboratory expansion. Overall, we learn that multisectoral involvement of laboratories from non-health sectors, an effective supply chain system with an insight into the promotion of local production of laboratory supplies were critical during the laboratory expansion for COVID-19 testing. The consistent support from WHO and other implementing partners to Member States is needed in building the capacity of laboratories across different diagnostic capabilities in line with International Health Regulations. This will enable efficient adaptation to respond to future public health emergencies.

Identifiants

pubmed: 33889234
doi: 10.11604/pamj.2021.38.68.27501
pii: PAMJ-38-68
pmc: PMC8028356
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright: Adisu Kebede et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

J Infect Dis. 2012 Dec 15;206 Suppl 1:S41-5
pubmed: 23169970
BMC Infect Dis. 2018 Sep 3;18(1):449
pubmed: 30176806

Auteurs

Adisu Kebede (A)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Betty Lanyero (B)

World Health Organization Ethiopia Country Office, UNECA Compound, Zambezi Building, Addis Ababa, Ethiopia.

Berhane Beyene (B)

World Health Organization Ethiopia Country Office, UNECA Compound, Zambezi Building, Addis Ababa, Ethiopia.

Mayur Lalji Mandalia (ML)

World Health Organization Liaison Office to the African Union and the UN Economic Commission for Africa, UNECA Compound, Zambezi Building, Addis Ababa, Ethiopia.

Daniel Melese (D)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Feven Girmachew (F)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Adamu Mekonnen (A)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Gonfa Ayana (G)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Nebiyou Yemanebirhan (N)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Getnet Hailu (G)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Habtamu Asrat (H)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Negash Nurahmed (N)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Andargachew Gashu (A)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Kirubel Eshetu (K)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Zewdu Assefa (Z)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Aschalew Abayneh (A)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Emmanuel Musa (E)

World Health Organization Regional Office for Africa, Brazzaville, Republic of Congo.

Ebba Abate (E)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH